Harrow, Inc. (HROW) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
About Harrow, Inc.
Harrow, Inc. is led by CEO Mark L. Baum, employs 382 people, headquartered in US, publicly traded since 2007.
Harrow, Inc. (HROW) stock trades at $28.44 with a market capitalization of $1.07B. The stock is valued at a negative price-to-earnings (P/E) ratio of -30.94, reflecting a net loss over the last twelve months, price-to-book of 75.46, price-to-sales of 4.15. Over the past 52 weeks the stock has ranged between $27.24 and $54.85, and currently trades 48.1% below its 52-week high.
On profitability, Harrow, Inc. generates a return on equity (ROE) of -103.86% (negative, reflecting a net loss), return on capital employed of 1.81%, an operating margin of 10.47%, a net profit margin of -13.51%.
Harrow, Inc. by the numbers, 2016–2025
Between 2016 and 2025 Harrow, Inc. reported revenue of $20.0M rising to $272.0M, a change of +1260.0% across 10 years. Compounded, revenue has grown 40.9% a year over five years, 45.1% over three, 36.0% over the last twelve months. Net profit rose to $-5.0M.
Operating margin went from -79.6% in 2016 to 14.2% in 2025, a gain of 93.8 percentage points. The most recent net margin is -13.51%. On a trailing twelve-month basis to Jun '26, revenue is $276.0M and net profit $-37.0M.
Borrowings rose from $14.0M to $252.0M, cash from operations was $44.0M in the latest year, positive in 6 of the last 10.
Return on equity has averaged -56.4% over five years, and was -9.6% in the most recent year.
The share price itself has compounded at 36.0% a year over five years, 27.6% over three, 28.1% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Harrow, Inc. (HROW) — frequently asked questions
What is Harrow, Inc. (HROW) stock price today?
Harrow, Inc. (HROW) is currently trading at $28.44, up 1.03% today.
What is HROW P/E ratio?
Harrow, Inc.'s P/E ratio is -30.94. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is HROW return on equity (ROE)?
Harrow, Inc.'s return on equity (ROE) is -103.86%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Harrow, Inc.'s market cap?
Harrow, Inc. has a market capitalization of $1.07B.
Does HROW pay a dividend?
Harrow, Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does HROW carry?
Harrow, Inc. has a debt-to-equity ratio of 19.79. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is HROW's profit margin?
Harrow, Inc. reports a net profit margin of -13.51% — the share of revenue left after every cost, including tax and interest.
What sector is HROW in?
Harrow, Inc. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is HROW listed on?
Harrow, Inc. trades on NASDAQ under the ticker HROW.
What is HROW's 52-week range?
Over the last year Harrow, Inc. has traded between $27.24 and $54.85.
Related Healthcare Stocks
Popular Stocks
Screens HROW currently matches
On the figures above, Harrow, Inc. passes the filters for 7 of our ready-made screens, among them Small Cap Stocks, Most Shorted Stocks, High Debt to Equity Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.